Uncovering Protein Biology of Neurodegeneration at Scale

Register below for our speaker session

What the Global Neurodegeneration Proteomics Consortium Has Learned (so far) from SomaScan Proteomics Across Multiple Cohorts

Tuesday, July 29 l 1:05–1:45 pm
Stage #2
(in front of aisle 1600 in the exhibit hall)

The Global Neurodegeneration Proteomics Consortium (GNPC) represents a groundbreaking public-private partnership that has assembled one of the world’s largest SomaScan™ Assay proteomic datasets.

This product feature will showcase transformative findings from the GNPC, including:

• Discovery of novel protein signatures for predicting major forms of dementia and neurodegenerative conditions
• Identification of multiple underlying pathologies through comprehensive protein profiling
• Mechanistic insights derived from complex protein network analysis
• Large-scale proteomic findings across diverse patient cohorts

Speakers

 • Farhad Imam, Gates Ventures
 • Clare Paterson, StandardBioTools
 • Jacob Vogel, Lund University